This case involves a female patient with a history of alcohol abuse that presented to the hospital with abdominal pain. She was diagnosed with acute pancreatitis and developed alcohol withdrawal soon after starting her treatment. She was admitted to the ICU and put on a Lorazepam sedative drip as well as BiPAP ventilation. After a few hours, the patient showed enough improvement that she was taken off the BiPAP. In the middle of the night, the patient was found unresponsive. She was given a chest X-ray, which showed a large fluid build-up in her lungs. The patient subsequently went into cardiopulmonary arrest resulting in total loss of brain function. An expert in ICU nursing was requested to discuss the type of ICU monitoring for patients with alcohol withdrawal and opine on whether intubation was necessary under these circumstances.
Question(s) For Expert Witness
1. What type of monitoring is necessary for patients in alcohol withdrawal on a Lorazepam drip?
2. When should one consider intubation for airway protection?
Expert Witness Response E-122210
Intubation is considered for a variety of reasons, such as respiratory distress, a progression of neurological disorders, and inability to protect the airway and when patients are deteriorating with concern for possible respiratory failure. Some indicators are carbon dioxide retention, low oxygen saturation, extreme alkalosis or acidosis on ABG. Lorazepam drips require frequent maintenance monitoring for high risk of over-sedation. These patients should be on continuous monitoring including oxygen saturation but preferably end-tidal CO2. The fact that Ativan was being used for alcohol withdraw means monitoring for worsening symptoms of withdrawal is also needed. Depending on how long the patient is on the drip, the dose and prior assessment frequency could reasonably be anywhere from 15 minutes to 1 hour. Having worked ICU for 15 years in both Neuro and Trauma, this type of patient is commonly seen in units I have worked. I have represented plaintiffs and defendants in cases regarding respiratory failure that resulted in patient death not necessarily for the same reason. For example, I represented the defendant in a case of respiratory failure of a teenager due to myasthenia gravis, an adult with PE bilaterally and ICH.
About the author
Victoria Negron
Victoria Negron has extensive experience in journalism and thought leadership in the legal space, with a background crafting content, whitepapers, webinars, and current event articles pertaining to the role of expert witnesses in complex litigation matters. She is a skilled professional specializing in B2B product marketing and content marketing. Currently, she serves as an Enterprise Product Marketing Manager at Postman, and previously held the position of Technical Product Marketing Manager at Palantir Technologies, where she developed her skills in launch strategies, go-to-market strategy, and competitive analysis.
Her expertise in content marketing was further refined during her tenure at the Expert Institute, where she progressed from a Marketing Writer to Senior Content Marketing Manager, and eventually to Associate Director of Content & Product Marketing. In these roles, she honed her abilities in digital marketing, SEO, content strategy, and thought leadership.
Educationally, Victoria holds a Master of Business Administration from the University of Florida - Warrington College of Business and a Bachelor of Arts in Literature, Art, and Hispanic Studies from Hamilton College. Her diverse educational background and professional experience have equipped her with a robust skill set in product marketing, content development, and strategic marketing initiatives.
